Erratum: A pilot study of pembrolizumab in smoldering myeloma: Report of the clinical, immune, and genomic analysis (Blood Advances (2019) 3: 15 (2400-2408) DOI: 10.1182/bloodadvances.2019000300)

E. E. Manasanch, G. Han, Rohit Mathur

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

In the second paragraph of “Acknowledgments” on page 2407, funding from the Chapman and Perelman Foundation was not mentioned. The error has been corrected in the published article.

Original languageEnglish (US)
Pages (from-to)2712
Number of pages1
JournalBlood Advances
Volume3
Issue number18
DOIs
StatePublished - Sep 24 2019

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Erratum: A pilot study of pembrolizumab in smoldering myeloma: Report of the clinical, immune, and genomic analysis (Blood Advances (2019) 3: 15 (2400-2408) DOI: 10.1182/bloodadvances.2019000300)'. Together they form a unique fingerprint.

Cite this